Delivery Order SPE2DB22D3016-SPE2DB25FAZT4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,127.41 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,170.56 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 30 mg on September 16, 2025, with completion targeted for September 17, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical products will be delivered to the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,062.60 for 100 capsules of Dextroamphetamine-Amphetamine 20 mg on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price contract requires performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued without a set-aside designation, reflecting open competition among qualified pharmaceutical...
- The Defense Logistics Agency awarded a $1,488.80 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 20 mg on May 23, 2025, with an ultimate completion date of May 27, 2025. This firm fixed-price delivery order is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,216.66 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100 count) on September 4, 2025, with an ultimate completion date of September 5, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.24 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a single delivery order issued under the...
- The Defense Logistics Agency awarded a $1,148.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg, with a completion date of September 12, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical supply will be delivered...
- The Defense Logistics Agency awarded a delivery order valued at $2,220.67 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency awarded a $1,325.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 10 mg on April 29, 2025, with completion expected by April 30, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at the...
- The Defense Logistics Agency issued a delivery order valued at $2,193.92 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 20 mg. The contract, awarded June 30, 2025, with completion by July 1, 2025, employs firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters. This delivery order is issued under...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAZT4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,130.67 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 20 mg on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price, non-set-aside contract was performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive IDC vehicle that supports military healthcare programs globally. The SPE2DX contract enables the company to supply a vast range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and vaccines to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for a controlled pharmaceutical demonstrates the vendor's role in fulfilling specific medical supply requirements across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/18/25 |